– Reuters
First Wave BioPharma Announces Exercise Of Warrants And Issuance Of New Warrants In A Private Placement For $2.4M Gross Proceeds Priced At-The-Market
First Wave BioPharma, Inc. ("First Wave BioPharma" or the "Company") (NASDAQ:FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI)
